Soleno Therapeutics, Inc. (SLNO)

Soleno Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	87.93	169.68	14.6	21.3	49.22
Short-Term Investments	203.51	-	-	-	-
Cash & Short-Term Investments	291.44	169.68	14.6	21.3	49.22
Cash Growth	71.76%	1062.04%	-31.46%	-56.72%	137.42%
Prepaid Expenses	2.45	1.68	1.05	1.12	1.02
Total Current Assets	293.89	171.36	15.65	22.42	50.24
Property, Plant & Equipment	2.98	0.42	0.16	0.45	0.16
Long-Term Investments	27.21	-	-	-	-
Other Intangible Assets	6.81	8.75	10.69	12.64	14.58
Other Long-Term Assets	0.08	0.17	-	0.04	-
Total Assets	330.97	180.69	26.5	35.55	64.98
Accounts Payable	8.88	3.15	1.78	3.25	3.49
Accrued Expenses	6.6	6.53	4.9	4.15	4.79
Current Portion of Leases	0.53	0.27	0.16	0.28	0.15
Other Current Liabilities	2.74	1.56	0.48	0.32	0.19
Total Current Liabilities	18.75	11.51	7.31	8.01	8.62
Long-Term Debt	49.83	-	-	-	-
Long-Term Leases	2.47	0.13	-	0.18	-
Other Long-Term Liabilities	14.81	11.55	8.84	9.58	10.82
Total Liabilities	85.86	23.18	16.15	17.76	19.44
Common Stock	0.05	0.03	0.01	0.08	0.08
Additional Paid-In Capital	696.97	433.89	247.76	231.07	227.91
Retained Earnings	-452.26	-276.41	-237.42	-213.36	-182.45
Comprehensive Income & Other	0.36	-	-	-	-
Total Common Equity	245.11	157.51	10.35	17.79	45.55
Shareholders' Equity	245.11	157.51	10.35	17.79	45.55
Total Liabilities & Equity	330.97	180.69	26.5	35.55	64.98
Total Debt	52.83	0.4	0.16	0.46	0.15
Net Cash (Debt)	265.82	169.28	14.45	20.85	49.08
Net Cash Growth	57.03%	1071.72%	-30.70%	-57.52%	142.19%
Net Cash Per Share	6.62	10.26	1.72	3.92	11.76
Filing Date Shares Outstanding	45.86	32.46	8.17	5.34	5.31
Total Common Shares Outstanding	45.7	31.68	8.16	5.32	5.31
Working Capital	275.14	159.85	8.33	14.42	41.63
Book Value Per Share	5.36	4.97	1.27	3.34	8.58
Tangible Book Value	238.31	148.76	-0.35	5.16	30.97
Tangible Book Value Per Share	5.21	4.70	-0.04	0.97	5.83
Machinery	0.2	0.1	0.1	0.1	0.05
Leasehold Improvements	0.05	-	-	-	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q